Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | APP | P05067 | 1/20 | 1.00 |
| ▸ | GBA1 | P04062 | 4/20 | 0.50 |
| ▸ | MGAM | O43451 | 6/20 | 0.33 |
| ▸ | FUCA1 | P04066 | 5/20 | 0.33 |
| ▸ | GLA | P06280 | 2/20 | 0.33 |
| ▸ | GANC | Q8TET4 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2512806 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL13207905 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL12711208 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL187278 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL21388397 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL13058696 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL12735687 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| SCHEMBL2511997 | 1.00 | — | — | |
| Inositol SCHEMBL2422938 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 | |
| Scyllitol SCHEMBL187397 | 1.00 | LMNA (1.00) | LMNAAPPGBA1MGAMFUCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3129463-B1 | COMPOUNDED MEDIA POWDER FORMULATION AND METHOD OF PREPARATION OF LIQUID MEDIUM FOR CELL CULTURE | BAYER HEALTHCARE LLC (US) | 2021-05-26 | — | — | EP | claimed |
| EP-3331987-A1 | TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE | Regeneron Pharmaceuticals, Inc. (US) | 2018-06-13 | — | — | EP | claimed |
| WO-2017024062-A1 | TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE | REGENERON PHARMACEUTICALS, INC. (US) | 2017-02-09 | — | — | WO | claimed |
| US-7964219-B2 | Pharmaceutical compositions for controlled release delivery of biologically active compounds | QPS, LLC (US) | 2011-06-21 | — | — | US | claimed |
| EP-1786400-B1 | PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | QUEST PHARMACEUTICAL SERVICES (US) | 2009-03-11 | — | — | EP | claimed |
| EP-1786400-A4 | PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | QUEST PHARMACEUTICAL SERVICES (US) | 2008-07-09 | — | — | EP | claimed |
| EP-1786400-A2 | PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | Quest Pharmaceutical Services (US) | 2007-05-23 | — | — | EP | claimed |
| US-20060034923-A1 | Pharmaceutical compositions for controlled release delivery of biologically active compounds | QUEST PHARMACEUTICAL SERVICES | 2006-02-16 | — | — | US | claimed |
| WO-2006017852-A2 | PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | QUEST PHARMACEUTICAL SERVICES (US) | 2006-02-16 | — | — | WO | claimed |
| US-20050101011-A1 | Cell culture media | MACROGENICS, INC. | 2005-05-12 | — | — | US | claimed |
| EP-1000541-B1 | Defined serumfree medical solution for ophthalmology | SKELNIK DEBRA L (US) | 2004-01-14 | — | — | EP | claimed |
| US-6153582-A | USED FOR PRESERVATION AND ENHANCEMENT OF HUMAN CORNEAL TISSUE, SPECIFIED AS THE TIME BETWEEN REMOVAL FROM THE DONOR AND TRANSPLANTATION | BAUSCH & LOMB SURGICAL, INC. (US) | 2000-11-28 | — | — | US | claimed |
| EP-1000541-A1 | Defined serumfree medical solution for ophthalmology | Bausch & Lomb Surgical, Inc. (US) | 2000-05-17 | — | — | EP | claimed |
| JP-3027339-A | — | — | None | — | — | JP | disclosed |
| JP-4193884-A | — | — | None | — | — | JP | disclosed |
| JP-61263902-A | — | — | None | — | — | JP | disclosed |
| US-3974035-A | CULTURES | MEIJI SEIKA KAISHA, LTD. (JA) | 1976-08-10 | — | — | US | disclosed |
| US-3956068-A | AMINOGLYCOSIDES | SCHERING CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
| US-RE28700-E | STREPTOMYCES | HOFFMANN-LA ROCHE INC. (US) | 1976-01-27 | — | — | US | disclosed |
| US-3931400-A | CULTIVATION OF MICROMONOSPORA, ANTIBIOTIC | ABBOTT LABORATORIES (US) | 1976-01-06 | — | — | US | disclosed |